Gilead is laying off 36 people as part of a rethink that saw the Big Pharma scrap plans to expand a biologics facility in ...

Analysts at Truist Securities called J&J’s CAR-T readout “compelling,” noting that the efficacy figures could position the ...

Live recording from the 'Serena Joy & Gabriel Wharton Centre For Kids Who Can't Read Good', aka the magnificent Library ...

Margaret Atwood’s chilling world of Gilead returns in The Testaments, the long-anticipated sequel to her groundbreaking novel ...

Gilead Sciences shows strong Q1 execution, pipeline momentum, and margin upside, led by HIV and PrEP launches. See why GILD ...

Gilead Sciences, Inc. (NASDAQ:GILD) is one of the 11 Best Drug Stocks to Buy According to Hedge Funds. Goldman Sachs analyst ...

The firm’s analysis suggests that high clinician engagement, lower-than-expected adherence to oral PrEP medications, and the ...

FARMERS across Region Six (East Berbice-Corentyne) are voicing their strong support for the Ministry of Agriculture, commending the ministry for its continued ...

Nick doubles down on being the villain when he’s back in New Bethlehem, and tells Rita that he no longer thinks he’s able to ...

The debate continues over the potential of measurable residual disease to transform research and clinical care in hematology.

Director Daina Reid joins Fiona and Haidee in the Eyes On Gilead Zoom room for a deep dive on her episodes of The Handmaid's ...

Gilead Sciences Inc. closed 8.32% below its 52-week high of $119.96, which the company reached on March 10th.